48 results match your criteria: "Targetoid Hemosiderotic Hemangioma"
Targetoid hemosiderotic hemangioma: A review article.
Semin Diagn Pathol
November 2024
University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216, United States. Electronic address:
Article Synopsis
- Targetoid hemosiderotic hemangioma (THH) is a rare vascular lesion that mainly affects adults, usually developing after trauma, with no significant gender preference.
- The review analyzes THH's characteristics, differentiating it from similar conditions like Kaposi's sarcoma and retiform hemangioendothelioma.
- Clinically, THH appears as painless lesions with a distinctive target-like look; histologically, it shows specific vascular features and can be identified with immunohistochemical markers.
Targetoid Hemosiderotic Hemangioma With Spontaneous Remission and Recurrence in a Male Patient: A Case Report.
Cureus
August 2024
Dermatology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Article Synopsis
- Targetoid hemosiderotic hemangioma is a rare, benign skin condition mostly seen in people in their 20s, typically affecting the trunk and lower limbs.
- It presents as a distinctive violaceous papule surrounded by a pale area and an ecchymotic ring, resembling a target.
- A case study describes a 23-year-old male with a recurring blue-black lesion on his shoulder, diagnosed as targetoid hemosiderotic hemangioma based on dermoscopic patterns.
Hobnail hemangioma of the conjunctiva.
Oman J Ophthalmol
October 2023
Larson and Toubro Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Targetoid Hemosiderotic Hemangioma: Two Rare Cases.
Indian J Dermatol
January 2023
From the Calcutta National Medical College and Hospital, Kolkata, West Bengal, India E-mail:
Recurrent targetoid hemosiderotic hemangioma with spontaneous resolution in a male.
Indian J Dermatol Venereol Leprol
January 2024
Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research (DMIHER) (Deemed to be University), Wardha, Maharashtra, India.
Targetoid Hemosiderotic Hemangioma (Hobnail Hemangioma).
J Cutan Med Surg
December 2023
Department of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
A Recurrent Case of Targetoid Hemosiderotic Hemangioma: A Case Report and a Comprehensive Review of the Literature.
Acta Dermatovenerol Croat
December 2020
Roxana Chiorean, MD, Frankfurter Str 90, PLZ 63110, Rodgau, Germany;
Article Synopsis
- Targetoid hemosiderotic hemangioma is a rare vascular skin condition of unknown cause, usually diagnosed through clinical and histological evaluations.
- A case study of a 31-year-old man with a 2 cm targetoid lesion on his arm highlighted symptoms like pain after pressure and unique dermoscopic findings.
- The investigation included reviewing six similar cases, noting that spontaneous regression and recurrence are uncommon for this kind of skin lesion.
Targetoid Hemosiderotic Hemangioma.
Indian Pediatr
October 2020
Department of Dermatology, Venereology, and Leprosy, RG Kar Medical College, Kolkata, West Bengal, India.
A pigmented papule acting like a playful ghost: dermoscopy of three targetoid hemosiderotic hemangiomas.
G Ital Dermatol Venereol
October 2018
Unit of Dermatology and Sexually-Trasmitted Diseases, P. Giaccone University Hospital, University of Palermo, Palermo, Italy.
Article Synopsis
- Targetoid hemosiderotic hemangioma is a rare, benign vascular lesion predominantly affecting people in their 20s and 30s, primarily located in the lower limbs and trunk.
- The study examined three dermoscopic cases and reviewed literature on this condition, highlighting demographic details, common appearances, and specific dermoscopic features.
- The findings aim to enhance understanding and diagnostic accuracy of targetoid hemosiderotic hemangiomas, especially distinguishing them from other similar lesions like melanoma.
Arborizing vessels in a targetoid hemosiderotic hemangioma: mistaken dermoscopic diagnosis of basal cell carcinoma.
Dermatol Pract Concept
January 2017
Institute of Histopathology, Histonor, Antofagasta, Chile.
Article Synopsis
- - Targetoid hemosiderotic hemangioma (THH) is a benign vascular tumor characterized by a ring-shaped appearance, featuring a central purple-brown spot and outer pale and bruised areas.
- - Dermoscopy can often help diagnose HH due to its distinct visual patterns, but in this case, the features were atypical, leading to a misdiagnosis.
- - The unusual presence of arborizing vessels in the dermoscopic pattern ultimately indicated a diagnosis of basocellular carcinoma (BCC), with changes observed over a year correlating with tissue analysis.
Hobnail Hemangioma With an Unusual Clinical Presentation.
J Cutan Med Surg
October 2017
1 Department of Dermatology, Complejo Hospitalario Universitario de Granada, Spain.
Article Synopsis
- * It has a distinct histological pattern with dilated and angulated blood vessels, and its origin is debated, though some studies suggest it may be a type of lymphatic malformation.
- * A case of a 41-year-old man with a larger and unusually located hobnail hemangioma on the scalp highlights the need for careful clinical and pathological analysis, especially for atypical presentations.
Hobnail Hemangioma (Superficial Hemosiderotic Lymphovascular Malformation) in Children: A Series of 6 Pediatric Cases and Review of the Literature.
J Cutan Med Surg
May 2016
Division of Pediatric Dermatology, Hospital for Sick Kids, Toronto, Canada.
Article Synopsis
- Hobnail hemangioma is a benign vascular malformation found mainly in the superficial and mid-dermis that can present in various ways.
- A review of cases from 2000 to 2014 found 4 male and 2 female pediatric patients, with most lesions appearing on the extremities and some being congenital.
- While hobnail hemangiomas are generally harmless and may not need treatment, surgical excision is the most effective option if intervention is necessary.
Dermoscopy of Targetoid Hemosiderotic Hemangioma: A Morphological Study of 35 Cases.
Dermatology
August 2016
Dermatology Department, Hospital Sant Pau i Santa Tecla, Tarragona, Spain.
Article Synopsis
- Targetoid hemosiderotic hemangioma is a rare, benign lesion that resembles melanoma, making accurate diagnosis challenging.
- A study analyzed 35 confirmed cases to identify common dermoscopic features, revealing a specific pattern in 71.4% of cases.
- Dermoscopy enhances diagnosis accuracy but caution is needed as some hemangiomas may display non-targetoid patterns that could be confused with more serious lesions.
Dermoscopic misdiagnosis of melanoma in a patient with targetoid hemosiderotic hemangioma.
J Am Acad Dermatol
November 2014
Department of Dermatology and Venereology, Second University of Naples, Naples, Italy.
Targetoid hemosiderotic hemangioma.
Indian Dermatol Online J
October 2014
Departments of Dermatology, Surgery, Dr. L. H. Hiranandani Hospital, Powai, Mumbai, Maharashtra, India.
Targetoid hemosiderotic hemangioma - Case report.
An Bras Dermatol
April 2015
Hospital São Marcos, Teresina, PI, Brazil.
Article Synopsis
- Targetoid Hemosiderotic Hemangioma, or Hobnail Hemangioma, is a vascular lesion typically appearing as a single purple bump with a light ring and bruising around it, resembling a target.
- It has a distinct histological appearance with swollen blood vessels near the surface and a unique deep dermis pattern, featuring hobnail-shaped endothelial cells.
- The condition is rare but can be effectively treated with a simple surgical excision.
[Targetoid hemosiderotic hemangioma].
An Pediatr (Barc)
February 2015
Sección de Dermatología Pediátrica, Hospital Universitario La Paz, Madrid, España.
Superficial hemosiderotic lymphovascular malformation (hobnail hemangioma): a report of six cases.
Pediatr Dermatol
December 2014
Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Article Synopsis
- - Hobnail hemangioma (HH) is a rare skin lesion typically seen in children and young to middle-aged adults, characterized by a central brown or violet nodule often with a surrounding ecchymotic halo.
- - Recent studies suggest that HHs may originate from lymphatic tissues, despite the exact cause still being unclear.
- - The authors propose renaming this condition to "superficial hemosiderotic lymphovascular malformation" to better reflect its characteristics and promote more accurate diagnosis, avoiding confusion with hemangiomas.
Targetoid hemosiderotic hemangioma: a case report of multiple asymptomatic lesions.
Cutis
August 2013
700 W Jefferson St, Kirksville, MO 63501, USA.
Article Synopsis
- Targetoid hemosiderotic hemangioma (THH) is a benign vascular tumor that typically appears as a central purplish spot surrounded by a clear area and an outer bruise-like ring.
- While THH is often associated with hemosiderin deposits, not all cases exhibit this classic appearance.
- A unique case is reported where a patient had multiple THH lesions without any previous trauma, making this presentation unusual compared to typical cases linked to minor injury.
Targetoid hemosiderotic hemangioma (Hobnail Hemangioma): typical clinical and histological presentation.
Chin Med J (Engl)
April 2014
Department of Dermatology, Beijing Hospital, Beijing 100730, China.
Congenital and multiple hobnail hemangiomas.
Ann Dermatol
November 2011
Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
Hobnail hemangioma (targetoid hemosiderotic hemangioma) is a vascular tumor affecting the limbs or trunk. Characteristically, the lesion has a "targetoid" clinical feature and dilated vascular spaces lined by hobnail endothelial cells at histologic examination. The age of onset is widely variable, form 5~67 years, typically occurring in young or middle-aged persons.
View Article and Find Full Text PDFTargetoid hemosiderotic hemangiomas (hobnail hemangiomas) are vascular lymphatic malformations: a study of 12 pediatric cases.
J Am Acad Dermatol
January 2012
Division of Dermatology, CHU Sainte Justine, University of Montreal, Montreal, Quebec, Canada.
Article Synopsis
- Targetoid hemosiderotic hemangioma (THH), or hobnail hemangioma, is a benign vascular lesion thought to originate from lymphatic tissue.
- A study was conducted on 12 pediatric cases of THH to analyze clinical and histopathologic data, including the presence of lymphatic vessels using immunostaining techniques.
- The results indicated that THH should be considered a lymphatic vascular malformation, with low proliferation potential, though the small sample size is a limitation of the study.
Recurrent targetoid hemosiderotic hemangioma in a 26-year-old man.
J Am Osteopath Assoc
February 2011
Department of Aviation Medicine, Naval Hospital Oak Harbor, 3475 N Saratoga St, Oak Harbor, WA 98278-4927, USA.
Article Synopsis
- - A 26-year-old healthy man had a 6-mm purple bump with a 1.5-cm red ring around it on his right side, which had been recurring for 4-5 years.
- - The condition was diagnosed as targetoid hemosiderotic hemangioma, a type of skin lesion.
- - The lesion was surgically removed, leading to resolution, and the authors explored its appearance, microscopic structure, and possible causes.
Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases.
J Am Acad Dermatol
December 2010
Division of Dermatology, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.
Article Synopsis
- Vascular tumors and malformations often mimic each other, but they require different approaches for diagnosis and treatment, with the WT1 gene playing a role in many tumors.* -
- This study evaluated WT1 expression in 126 vascular lesions, finding that all vascular tumors showed positive WT1 staining, while only a few vascular malformations did.* -
- The results suggest that WT1 immunohistochemistry can help differentiate between vascular tumors and malformations, potentially guiding clinicians in complex cases.*
Clinicopathologic challenge. Targetoid hemosiderotic hemangioma.
Int J Dermatol
October 2008
Department of Dermatology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.